Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1971 2
1983 4
1984 3
1985 1
1986 3
1987 3
1988 1
1989 3
1990 1
1991 1
1992 5
1993 7
1994 5
1995 1
1996 4
1997 2
1998 4
1999 6
2000 6
2001 2
2002 2
2003 2
2004 7
2005 2
2006 3
2007 6
2008 8
2009 5
2010 7
2011 8
2012 10
2013 15
2014 19
2015 13
2016 16
2017 14
2018 17
2019 14
2020 13
2021 11
2022 9
2023 15
2024 12
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Results by year

Filters applied: . Clear all
Page 1
Regulation of Intestinal Barrier Function by Microbial Metabolites.
Ghosh S, Whitley CS, Haribabu B, Jala VR. Ghosh S, et al. Among authors: whitley cs. Cell Mol Gastroenterol Hepatol. 2021;11(5):1463-1482. doi: 10.1016/j.jcmgh.2021.02.007. Epub 2021 Feb 18. Cell Mol Gastroenterol Hepatol. 2021. PMID: 33610769 Free PMC article. Review.
Sanfilippo syndrome: consensus guidelines for clinical care.
Muschol N, Giugliani R, Jones SA, Muenzer J, Smith NJC, Whitley CB, Donnell M, Drake E, Elvidge K, Melton L, O'Neill C; MPS III Guideline Development Group. Muschol N, et al. Among authors: whitley cb. Orphanet J Rare Dis. 2022 Oct 27;17(1):391. doi: 10.1186/s13023-022-02484-6. Orphanet J Rare Dis. 2022. PMID: 36303195 Free PMC article. Review.
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ; Fabry Disease Clinical Trial Study Group. Banikazemi M, et al. Among authors: whitley cb. Ann Intern Med. 2007 Jan 16;146(2):77-86. doi: 10.7326/0003-4819-146-2-200701160-00148. Epub 2006 Dec 18. Ann Intern Med. 2007. PMID: 17179052 Free article. Clinical Trial.
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Diaz-Manera J, et al. Lancet Neurol. 2021 Dec;20(12):1012-1026. doi: 10.1016/S1474-4422(21)00241-6. Lancet Neurol. 2021. PMID: 34800399 Clinical Trial.
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.
Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. JAMA Neurol. 2023 Jun 1;80(6):558-567. doi: 10.1001/jamaneurol.2023.0552. JAMA Neurol. 2023. PMID: 37036722 Free PMC article. Clinical Trial.
Two Decades of WORLDSymposium™.
Whitley CB. Whitley CB. Mol Genet Metab. 2024 Feb;141(2):108107. doi: 10.1016/j.ymgme.2023.108107. Epub 2023 Dec 12. Mol Genet Metab. 2024. PMID: 38155037 No abstract available.
Adams-Oliver syndrome revisited.
Whitley CB, Gorlin RJ. Whitley CB, et al. Am J Med Genet. 1991 Sep 1;40(3):319-26. doi: 10.1002/ajmg.1320400315. Am J Med Genet. 1991. PMID: 1951437 Review.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Chitotriosidase as a biomarker for gangliosidoses.
Kim S, Whitley CB, Jarnes JR. Kim S, et al. Among authors: whitley cb. Mol Genet Metab Rep. 2021 Oct 1;29:100803. doi: 10.1016/j.ymgmr.2021.100803. eCollection 2021 Dec. Mol Genet Metab Rep. 2021. PMID: 34646735 Free PMC article.
Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extension.
Ramaswami U, Font-Montgomery E, Goker-Alpan O, Ortiz D, Sanchez-Valle A, Whitley CB, Wilcox WR, Jiang H, Lawson LA, Vosk J, Yang H, Hopkin RJ. Ramaswami U, et al. Among authors: whitley cb. Mol Genet Metab. 2025 May;145(1):109102. doi: 10.1016/j.ymgme.2025.109102. Epub 2025 Apr 2. Mol Genet Metab. 2025. PMID: 40215726 Free article. Clinical Trial.
263 results